Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020.
COVID-19
Pertussis
epidemiology
lockdown
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
28
6
2022
Statut:
ppublish
Résumé
BackgroundInterventions to mitigate the COVID-19 pandemic may impact other respiratory diseases.AimsWe aimed to study the course of pertussis in France over an 8-year period including the beginning of the COVID-19 pandemic and its association with COVID-19 mitigation strategies, using multiple nationwide data sources and regression models.MethodsWe analysed the number of French pertussis cases between 2013 and 2020, using PCR test results from nationwide outpatient laboratories (Source 1) and a network of the paediatric wards from 41 hospitals (Source 2). We also used reports of a national primary care paediatric network (Source 3). We conducted a quasi-experimental interrupted time series analysis, relying on negative binomial regression models. The models accounted for seasonality, long-term cycles and secular trend, and included a binary variable for the first national lockdown (start 16 March 2020).ResultsWe identified 19,039 pertussis cases from these data sources. Pertussis cases decreased significantly following the implementation of mitigation measures, with adjusted incidence rate ratios of 0.10 (95% CI: 0.04-0.26) and 0.22 (95% CI: 0.07-0.66) for Source 1 and Source 2, respectively. The association was confirmed in Source 3 with a median of, respectively, one (IQR: 0-2) and 0 cases (IQR: 0-0) per month before and after lockdown (p = 0.0048).ConclusionsThe strong reduction in outpatient and hospitalised pertussis cases suggests an impact of COVID-19 mitigation measures on pertussis epidemiology. Pertussis vaccination recommendations should be followed carefully, and disease monitoring should be continued to detect any resurgence after relaxation of mitigation measures.
Identifiants
pubmed: 35748301
doi: 10.2807/1560-7917.ES.2022.27.25.2100933
pmc: PMC9229195
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Lancet Infect Dis. 2017 Sep;17(9):974-980
pubmed: 28623146
J Med Virol. 2021 Jan;93(1):153-154
pubmed: 32617991
Lancet Infect Dis. 2022 Feb;22(2):265-273
pubmed: 34672963
Proc Biol Sci. 2016 Jan 13;283(1822):
pubmed: 26763701
Vaccine. 2021 Jan 15;39(3):505-511
pubmed: 33357956
Euro Surveill. 2020 Nov;25(47):
pubmed: 33243355
Vaccine. 2017 Oct 27;35(45):6083-6088
pubmed: 28974408
Int J Environ Res Public Health. 2021 Jun 03;18(11):
pubmed: 34205018
Pediatr Infect Dis J. 2015 Aug;34(8):814-20
pubmed: 25955837
Pediatr Infect Dis J. 2021 Dec 1;40(12):e511-e514
pubmed: 34260480
JAMA. 2021 Jun 8;325(22):2247-2248
pubmed: 34028492
Clin Infect Dis. 2021 Nov 2;73(9):e2829-e2830
pubmed: 33594407
Front Pediatr. 2021 May 28;9:666848
pubmed: 34123969
Infect Dis Now. 2021 Aug;51(5):418-423
pubmed: 33991720
BMJ. 2015 Jun 09;350:h2750
pubmed: 26058820
J Med Virol. 2021 Mar;93(3):1814-1816
pubmed: 33079384
J Clin Microbiol. 2016 Aug;54(8):2169-71
pubmed: 27194689
Eur J Clin Microbiol Infect Dis. 2021 Nov;40(11):2389-2395
pubmed: 34347190
Lancet Infect Dis. 2018 Jan;18(1):5-6
pubmed: 29066129
N Engl J Med. 2012 Aug 30;367(9):785-7
pubmed: 22894554
Clin Infect Dis. 2021 Jan 27;72(2):319-322
pubmed: 33501967
Pediatr Pulmonol. 2021 Dec;56(12):3669-3673
pubmed: 34473914
Clin Infect Dis. 2021 Apr 8;72(7):e184-e191
pubmed: 33150393
Commun Dis Intell (2018). 2021 Feb 26;45:
pubmed: 33632091
Arch Dis Child. 2022 Mar;107(3):e19
pubmed: 34857511